Ellena Growcott
Overview
Explore the profile of Ellena Growcott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ledo A, Dimke T, Tschantz W, Rowlands D, Growcott E
Int J Pharm
. 2023 Oct;
647:123519.
PMID: 37852310
Inhaled antibody therapy for the treatment of respiratory diseases is a promising strategy to maximize pulmonary exposure and reduce side effects associated with parenteral administration. However, the development of inhaled...
2.
Ledo A, Thibodeaux S, Duong L, Altinoglu E, Dimke T, Shaw D, et al.
Eur J Pharm Biopharm
. 2023 May;
188:201-216.
PMID: 37196872
Inhaled therapy confers key advantages for the treatment of topical pulmonary diseases and offers potential for systemic delivery of medicines. Dry powder inhalers (DPIs) are generally the preferred devices for...
3.
Reck F, Bermingham A, Blais J, Casarez A, Colvin R, Dean C, et al.
ACS Infect Dis
. 2019 Mar;
5(7):1045-1051.
PMID: 30861342
Resistance in Gram-negative bacteria to β-lactam drugs is mediated primarily by the expression of β-lactamases, and co-dosing of β-lactams with a β-lactamase inhibitor (BLI) is a clinically proven strategy to...
4.
Banner K, de Jonge H, Elborn S, Growcott E, Gulbins E, Konstan M, et al.
J Cyst Fibros
. 2008 Nov;
8(1):1-8.
PMID: 19022708
A workshop to discuss anti-inflammatory approaches in the treatment of CF was held at Novartis Institutes for Biomedical Research (NIBR, Horsham, UK) in March 2008. Key opinion leaders in the...